{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T05:23:45Z","timestamp":1708925025872},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Brazilian National Research Council"},{"name":"Intramural Funding- Food and Drug Administration"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vaccination with live attenuated <jats:italic>Leishmania<\/jats:italic> parasites such as centrin deleted <jats:italic>Leishmania donovani<\/jats:italic> (<jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup>) against visceral leishmaniasis has been reported extensively. The protection induced by <jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> parasites was mediated by both CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells. While the host immune mediators of protection are known, parasite determinants that affect the CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cell populations remain unknown. Parasite encoded inflammatory cytokine MIF has been shown to modulate the T cell differentiation characteristics by altering the inflammation induced apoptosis during contraction phase in experimental infections with <jats:italic>Leishmania<\/jats:italic> or <jats:italic>Plasmodium<\/jats:italic>. Neutralization of parasite encoded MIF either by antibodies or gene deletion conferred protection in <jats:italic>Plasmodium<\/jats:italic> and <jats:italic>Leishmania<\/jats:italic> studies. We investigated if the immunogenicity and protection induced by <jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> parasites is affected by deleting MIF genes from this vaccine strain. Our results showed that <jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup><jats:italic>MIF<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> immunized group presented higher percentage of CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> central memory T cells, increased CD8<jats:sup>+<\/jats:sup> T cell proliferation after challenge compared to <jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> immunization. <jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup><jats:italic>MIF<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> immunized group presented elevated production of IFN-\u03b3<jats:sup>+<\/jats:sup> and TNF-\u03b1<jats:sup>+<\/jats:sup> CD4<jats:sup>+<\/jats:sup> T cells concomitant with a reduced parasite load in spleen and liver compared to <jats:italic>LdCen<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup>group following challenge with <jats:italic>L. infantum<\/jats:italic>. Our results demonstrate the role of parasite induced factors involved in protection and long-term immunity of vaccines against VL.<\/jats:p>","DOI":"10.1038\/s41598-023-34333-2","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:01:50Z","timestamp":1683302510000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deletion of MIF gene from live attenuated LdCen\u2212\/\u2212 parasites enhances protective CD4+ T cell immunity"],"prefix":"10.1038","volume":"13","author":[{"given":"Jacqueline Ara\u00fajo","family":"Fiuza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivas","family":"Gannavaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya Torres","family":"Gaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Gambogi","family":"de Ornellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rica Alessandra","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevien","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira Lal","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Correa-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"issue":"5","key":"34333_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar, J. et al. Leishmaniasis worldwide and global estimates of its incidence. WHO Leishmaniasis Control Team. PLoS ONE 7(5), e35671. https:\/\/doi.org\/10.1371\/journal.pone.0035671 (2012).","journal-title":"PLoS ONE"},{"issue":"2","key":"34333_CR2","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1371\/journal.pntd.0000114","volume":"1","author":"CD Mathers","year":"2007","unstructured":"Mathers, C. D., Ezzati, M. & Lopez, A. D. Measuring the burden of neglected tropical diseases: The global burden of disease framework. PLoS Negl. Trop. Dis. 1(2), e114. https:\/\/doi.org\/10.1371\/journal.pntd.0000114 (2007).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"11","key":"34333_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/14787210.2018.1532790","volume":"16","author":"S Sundar","year":"2018","unstructured":"Sundar, S., Singh, O. P. & Chakravarty, J. Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence. Expert Rev. Anti Infect. Ther. 16(11), 805\u2013812. https:\/\/doi.org\/10.1080\/14787210.2018.1532790 (2018).","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"Suppl","key":"34333_CR4","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1017\/S0031182006001831","volume":"133","author":"L Kedzierski","year":"2006","unstructured":"Kedzierski, L., Zhu, Y. & Handman, E. Leishmania vaccines: Progress and problems. Parasitology 133(Suppl), S87-112. https:\/\/doi.org\/10.1017\/S0031182006001831 (2006).","journal-title":"Parasitology"},{"issue":"3","key":"34333_CR5","first-page":"423","volume":"123","author":"A Khamesipour","year":"2006","unstructured":"Khamesipour, A., Rafati, S., Davoudi, N., Maboudi, F. & Modabber, F. Leishmaniasis vaccine candidates for development: A global overview. Indian J. Med. Res. 123(3), 423\u2013438 (2006).","journal-title":"Indian J. Med. Res."},{"issue":"3","key":"34333_CR6","first-page":"245","volume":"123","author":"S Saha","year":"2006","unstructured":"Saha, S. et al. Immune responses in kala-azar. Indian J. Med. Res. 123(3), 245\u2013266 (2006).","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"34333_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13071-020-04138-7","volume":"13","author":"SA Ejazi","year":"2020","unstructured":"Ejazi, S. A. et al. Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasis. Parasit. Vectors 13(1), 272. https:\/\/doi.org\/10.1186\/s13071-020-04138-7 (2020).","journal-title":"Parasit. Vectors"},{"key":"34333_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","volume":"10","author":"M Moafi","year":"2019","unstructured":"Moafi, M., Rezvan, H., Sherkat, R. & Taleban, R. Leishmania vaccines entered in clinical trials: A review of literature. Int. J. Prev. Med. 10, 95. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_116_18 (2019).","journal-title":"Int. J. Prev. Med."},{"issue":"1\u20132","key":"34333_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0304-4017(01)00486-1","volume":"100","author":"L Gradoni","year":"2001","unstructured":"Gradoni, L. An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Vet. Parasitol. 100(1\u20132), 87\u2013103. https:\/\/doi.org\/10.1016\/s0304-4017(01)00486-1 (2001).","journal-title":"Vet. Parasitol."},{"issue":"2","key":"34333_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","volume":"14","author":"E Handman","year":"2001","unstructured":"Handman, E. Leishmaniasis: Current status of vaccine development. Clin. Microbiol. Rev. 14(2), 229\u2013243. https:\/\/doi.org\/10.1128\/CMR.14.2.229-243.2001 (2001).","journal-title":"Clin. Microbiol. Rev."},{"issue":"14","key":"34333_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","volume":"26","author":"CB Palatnik-de-Sousa","year":"2008","unstructured":"Palatnik-de-Sousa, C. B. Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 26(14), 1709\u20131724. https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.023 (2008).","journal-title":"Vaccine"},{"issue":"4","key":"34333_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","volume":"15","author":"AP Fernandes","year":"2012","unstructured":"Fernandes, A. P., Coelho, E. A., Machado-Coelho, G. L., Grimaldi, G. Jr. & Gazzinelli, R. T. Making an anti-amastigote vaccine for visceral leishmaniasis: Rational, update and perspectives. Curr. Opin. Microbiol. 15(4), 476\u2013485. https:\/\/doi.org\/10.1016\/j.mib.2012.05.002 (2012).","journal-title":"Curr. Opin. Microbiol."},{"issue":"2","key":"34333_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00005-008-0010-9","volume":"56","author":"R Silvestre","year":"2008","unstructured":"Silvestre, R., Cordeiro-da-Silva, A. & Ouaissi, A. Live attenuated Leishmania vaccines: A potential strategic alternative. Arch. Immunol. Ther. Exp. 56(2), 123\u2013126. https:\/\/doi.org\/10.1007\/s00005-008-0010-9 (2008).","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"3","key":"34333_CR14","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","volume":"183","author":"A Selvapandiyan","year":"2009","unstructured":"Selvapandiyan, A. et al. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis. J. Immunol. 183(3), 1813\u20131820. https:\/\/doi.org\/10.4049\/jimmunol.0900276 (2009).","journal-title":"J. Immunol."},{"issue":"14","key":"34333_CR15","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","volume":"31","author":"JA Fiuza","year":"2013","unstructured":"Fiuza, J. A. et al. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs. Vaccine 31(14), 1785\u20131792. https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.048 (2013).","journal-title":"Vaccine"},{"issue":"2","key":"34333_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","volume":"33","author":"JA Fiuza","year":"2015","unstructured":"Fiuza, J. A. et al. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum. Vaccine 33(2), 280\u2013288. https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.039 (2015).","journal-title":"Vaccine"},{"issue":"1","key":"34333_CR17","doi-asserted-by":"publisher","first-page":"e0004322","DOI":"10.1371\/journal.pntd.0004322","volume":"10","author":"JA Fiuza","year":"2016","unstructured":"Fiuza, J. A. et al. Intradermal immunization of Leishmania donovani centrin knock-out parasites in combination with salivary protein LJM19 from sand fly vector induces a durable protective immune response in hamsters. PLoS Negl. Trop. Dis. 10(1), e0004322. https:\/\/doi.org\/10.1371\/journal.pntd.0004322 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"34333_CR18","doi-asserted-by":"publisher","first-page":"e0004963","DOI":"10.1371\/journal.pntd.0004963","volume":"10","author":"P Bhattacharya","year":"2016","unstructured":"Bhattacharya, P. et al. Live attenuated Leishmania donovani centrin knock out parasites generate non-inferior protective immune response in aged mice against visceral leishmaniasis. PLoS Negl. Trop. Dis. 10(8), e0004963. https:\/\/doi.org\/10.1371\/journal.pntd.0004963 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"34333_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1700674","volume":"200","author":"A Banerjee","year":"2018","unstructured":"Banerjee, A. et al. Live attenuated Leishmania donovani centrin gene-deleted parasites induce IL-23-dependent IL-17-protective immune response against visceral leishmaniasis in a murine model. J. Immunol. 200(1), 163\u2013176. https:\/\/doi.org\/10.4049\/jimmunol.1700674 (2018).","journal-title":"J. Immunol."},{"key":"34333_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3389\/fimmu.2018.01176","volume":"9","author":"RK Singh","year":"2018","unstructured":"Singh, R. K. et al. Centrin-deleted Leishmania donovani parasites help CD4+ T cells to acquire Th1 phenotype and multi-functionality through downregulation of CD200-CD200R immune inhibitory axis. Front. Immunol. 9, 1176. https:\/\/doi.org\/10.3389\/fimmu.2018.01176 (2018).","journal-title":"Front. Immunol."},{"key":"34333_CR21","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3389\/fimmu.2019.02273","volume":"10","author":"S Gannavaram","year":"2019","unstructured":"Gannavaram, S. et al. miR-21 expression determines the early vaccine immunity induced by LdCen\u2212\/\u2212 immunization. Front. Immunol. 10, 2273. https:\/\/doi.org\/10.3389\/fimmu.2019.02273 (2019).","journal-title":"Front. Immunol."},{"issue":"3","key":"34333_CR22","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.4049\/jimmunol.166.3.1921","volume":"166","author":"JA Streit","year":"2001","unstructured":"Streit, J. A., Recker, T. J., Filho, F. G., Beverley, S. M. & Wilson, M. E. Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms. J. Immunol. 166(3), 1921\u20131929. https:\/\/doi.org\/10.4049\/jimmunol.166.3.1921 (2001).","journal-title":"J. Immunol."},{"issue":"24","key":"34333_CR23","doi-asserted-by":"publisher","first-page":"25703","DOI":"10.1074\/jbc.M402794200","volume":"279","author":"A Selvapandiyan","year":"2004","unstructured":"Selvapandiyan, A. et al. Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania. J. Biol. Chem. 279(24), 25703\u201325710. https:\/\/doi.org\/10.1074\/jbc.M402794200 (2004).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"34333_CR24","first-page":"455","volume":"123","author":"A Selvapandiyan","year":"2006","unstructured":"Selvapandiyan, A. et al. Genetically modified live attenuated parasites as vaccines for leishmaniasis. Indian J. Med. Res. 123(3), 455\u2013466 (2006).","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"34333_CR25","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1038\/s41467-020-17154-z","volume":"11","author":"WW Zhang","year":"2020","unstructured":"Zhang, W. W. et al. A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat. Commun. 11(1), 3461. https:\/\/doi.org\/10.1038\/s41467-020-17154-z (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"34333_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41541-022-00449-1","volume":"7","author":"G Volpedo","year":"2022","unstructured":"Volpedo, G. et al. Centrin-deficient Leishmania mexicana confers protection against new world cutaneous leishmaniasis. NPJ vaccines 7(1), 32. https:\/\/doi.org\/10.1038\/s41541-022-00449-1 (2022).","journal-title":"NPJ vaccines"},{"key":"34333_CR27","doi-asserted-by":"publisher","first-page":"790418","DOI":"10.3389\/fcimb.2021.790418","volume":"11","author":"R Sharma","year":"2022","unstructured":"Sharma, R. et al. Targeted deletion of centrin in Leishmania braziliensis using CRISPR-Cas9-based editing. Front. Cell. Infect. Microbiol. 11, 790418. https:\/\/doi.org\/10.3389\/fcimb.2021.790418 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"34333_CR28","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.4049\/jimmunol.1303145","volume":"193","author":"R Dey","year":"2014","unstructured":"Dey, R. et al. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana. J. Immunol. 193(7), 3513\u20133527. https:\/\/doi.org\/10.4049\/jimmunol.1303145 (2014).","journal-title":"J. Immunol."},{"issue":"4","key":"34333_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-o","volume":"5","author":"SG Reed","year":"1993","unstructured":"Reed, S. G. & Scott, P. T-cell and cytokine responses in leishmaniasis. Curr. Opin. Immunol. 5(4), 524\u2013531. https:\/\/doi.org\/10.1016\/0952-7915(93)90033-o (1993).","journal-title":"Curr. Opin. Immunol."},{"issue":"1\u20132","key":"34333_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0165-2478(98)00132-1","volume":"65","author":"A Kharazmi","year":"1999","unstructured":"Kharazmi, A. et al. T-cell response in human leishmaniasis. Immunol. Lett. 65(1\u20132), 105\u2013108. https:\/\/doi.org\/10.1016\/s0165-2478(98)00132-1 (1999).","journal-title":"Immunol. Lett."},{"issue":"1","key":"34333_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11101.x","volume":"209","author":"KA Rogers","year":"2002","unstructured":"Rogers, K. A. et al. Type 1 and type 2 responses to Leishmania major. FEMS Microbiol. Lett. 209(1), 1\u20137. https:\/\/doi.org\/10.1111\/j.1574-6968.2002.tb11101.x (2002).","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"34333_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","volume":"99","author":"J Alexander","year":"2005","unstructured":"Alexander, J. & Bryson, K. T helper (h)1\/Th2 and Leishmania: Paradox rather than paradigm. Immunol. Lett. 99(1), 17\u201323. https:\/\/doi.org\/10.1016\/j.imlet.2005.01.009 (2005).","journal-title":"Immunol. Lett."},{"issue":"5","key":"34333_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","volume":"21","author":"RN Coler","year":"2005","unstructured":"Coler, R. N. & Reed, S. G. Second-generation vaccines against leishmaniasis. Trends Parasitol. 21(5), 244\u2013249. https:\/\/doi.org\/10.1016\/j.pt.2005.03.006 (2005).","journal-title":"Trends Parasitol."},{"issue":"1","key":"34333_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1172\/JCI116570","volume":"92","author":"HW Ghalib","year":"1993","unstructured":"Ghalib, H. W. et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Investig. 92(1), 324\u2013329. https:\/\/doi.org\/10.1172\/JCI116570 (1993).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"34333_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1590\/s0074-02761999000100013","volume":"94","author":"BJ Holaday","year":"1999","unstructured":"Holaday, B. J. Immunotherapy for visceral leishmaniasis: Ability of factors produced during anti-leishmania responses of skin test positive adults to inhibit peripheral blood mononuclear cell activities associated with visceral leishmaniasis. Mem. Inst. Oswaldo Cruz 94(1), 55\u201366. https:\/\/doi.org\/10.1590\/s0074-02761999000100013 (1999).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"10","key":"34333_CR36","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::aid-immu2848>3.0.co;2-t","volume":"31","author":"ML Murphy","year":"2001","unstructured":"Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A. & Farrell, J. P. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31(10), 2848\u20132856. https:\/\/doi.org\/10.1002\/1521-4141(2001010)31:10%3c2848::aid-immu2848%3e3.0.co;2-t (2001).","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"34333_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nyl\u00e9n","year":"2007","unstructured":"Nyl\u00e9n, S. & Sacks, D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 28(9), 378\u2013384. https:\/\/doi.org\/10.1016\/j.it.2007.07.004 (2007).","journal-title":"Trends Immunol."},{"issue":"749\u2013795","key":"34333_CR38","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm, U., Klamp, T., Groot, M. & Howard, J. C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15(749\u2013795), 1997. https:\/\/doi.org\/10.1146\/annurev.immunol.15.1.749 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"34333_CR39","doi-asserted-by":"publisher","first-page":"864031","DOI":"10.3389\/fimmu.2022.864031","volume":"13","author":"N Ismail","year":"2022","unstructured":"Ismail, N. et al. Leishmania major centrin gene-deleted parasites generate skin resident memory T-cell immune response analogous to leishmanization. Front. Immunol. 13, 864031. https:\/\/doi.org\/10.3389\/fimmu.2022.864031 (2022).","journal-title":"Front. Immunol."},{"issue":"10","key":"34333_CR40","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1128\/IAI.00184-15","volume":"83","author":"P Bhattacharya","year":"2015","unstructured":"Bhattacharya, P. et al. Genetically modified live attenuated Leishmania donovani parasites induce innate immunity through classical activation of macrophages that direct the Th1 response in mice. Infect. Immun. 83(10), 3800\u20133815. https:\/\/doi.org\/10.1128\/IAI.00184-15 (2015).","journal-title":"Infect. Immun."},{"issue":"12","key":"34333_CR41","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.4049\/jimmunol.2000829","volume":"205","author":"P Bhattacharya","year":"2020","unstructured":"Bhattacharya, P. et al. Essential role of neutrophils in the protective immune response induced by a live attenuated leishmania vaccine. J. Immunol. 205(12), 3333\u20133347. https:\/\/doi.org\/10.4049\/jimmunol.2000829 (2020).","journal-title":"J. Immunol."},{"key":"34333_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fimmu.2016.00187","volume":"7","author":"S Gannavaram","year":"2016","unstructured":"Gannavaram, S. et al. Modulation of innate immune mechanisms to enhance leishmania vaccine-induced immunity: Role of coinhibitory molecules. Front. Immunol. 7, 187. https:\/\/doi.org\/10.3389\/fimmu.2016.00187 (2016).","journal-title":"Front. Immunol."},{"issue":"7","key":"34333_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13(7), 843\u2013850. https:\/\/doi.org\/10.1038\/nm1592 (2007).","journal-title":"Nat. Med."},{"issue":"8","key":"34333_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-3024.2009.01125.x","volume":"31","author":"DR Faria","year":"2009","unstructured":"Faria, D. R. et al. Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol. 31(8), 432\u2013439. https:\/\/doi.org\/10.1111\/j.1365-3024.2009.01125.x (2009).","journal-title":"Parasite Immunol."},{"issue":"3","key":"34333_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","volume":"26","author":"I Ramos","year":"2008","unstructured":"Ramos, I. et al. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response. Vaccine 26(3), 333\u2013344. https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.021 (2008).","journal-title":"Vaccine"},{"issue":"7","key":"34333_CR46","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1084\/jem.20092532","volume":"207","author":"PA Darrah","year":"2010","unstructured":"Darrah, P. A. et al. IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform. J. Exp. Med. 207(7), 1421\u20131433. https:\/\/doi.org\/10.1084\/jem.20092532 (2010).","journal-title":"J. Exp. Med."},{"issue":"2","key":"34333_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tvjl.2009.08.001","volume":"186","author":"E Papadogiannakis","year":"2010","unstructured":"Papadogiannakis, E. et al. Determination of CD4+ and CD8+ T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy. Vet. J. 186(2), 262\u2013263. https:\/\/doi.org\/10.1016\/j.tvjl.2009.08.001 (2010).","journal-title":"Vet. J."},{"issue":"10","key":"34333_CR48","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1371\/journal.pntd.0000845","volume":"4","author":"M Nateghi Rostami","year":"2010","unstructured":"Nateghi Rostami, M. et al. CD8+ T cells as a source of IFN-\u03b3 production in human cutaneous leishmaniasis. PLoS Negl. Trop. Dis. 4(10), e845. https:\/\/doi.org\/10.1371\/journal.pntd.0000845 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"34333_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-3024.2010.01268.x","volume":"33","author":"L Xin","year":"2011","unstructured":"Xin, L., Wanderley, J. L., Wang, Y., Vargas-Inchaustegui, D. A. & Soong, L. The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice. Parasite Immunol. 33(3), 170\u2013180. https:\/\/doi.org\/10.1111\/j.1365-3024.2010.01268.x (2011).","journal-title":"Parasite Immunol."},{"issue":"3","key":"34333_CR50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2249.2011.04430.x","volume":"165","author":"TS Keesen","year":"2011","unstructured":"Keesen, T. S. et al. CD4(+) T cells defined by their V\u03b2 T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Clin. Exp. Immunol. 165(3), 338\u2013351. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04430.x (2011).","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"34333_CR51","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.micinf.2012.02.006","volume":"14","author":"A Khamesipour","year":"2012","unstructured":"Khamesipour, A. et al. Phenotyping of circulating CD8+ T cell subsets in human cutaneous leishmaniasis. Microbes Infect. 14(9), 702\u2013711. https:\/\/doi.org\/10.1016\/j.micinf.2012.02.006 (2012).","journal-title":"Microbes Infect."},{"issue":"5","key":"34333_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4269\/ajtmh.2004.71.561","volume":"71","author":"A Hailu","year":"2004","unstructured":"Hailu, A., van der Poll, T., Berhe, N. & Kager, P. A. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. Am. J. Trop. Med. Hyg. 71(5), 561\u2013567 (2004).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"34333_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm0402-379","volume":"8","author":"V Appay","year":"2002","unstructured":"Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8(4), 379\u2013385. https:\/\/doi.org\/10.1038\/nm0402-379 (2002).","journal-title":"Nat. Med."},{"issue":"12","key":"34333_CR54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nri1254","volume":"3","author":"RA van Lier","year":"2003","unstructured":"van Lier, R. A., ten Berge, I. J. & Gamadia, L. E. Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 3(12), 931\u2013939. https:\/\/doi.org\/10.1038\/nri1254 (2003).","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"34333_CR55","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.4049\/jimmunol.172.11.6533","volume":"172","author":"AD Roberts","year":"2004","unstructured":"Roberts, A. D. & Woodland, D. L. Cutting edge: Effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J. Immunol. 172(11), 6533\u20136537. https:\/\/doi.org\/10.4049\/jimmunol.172.11.6533 (2004).","journal-title":"J. Immunol."},{"issue":"27","key":"34333_CR56","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff, C. A. et al. Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 102(27), 9571\u20139576. https:\/\/doi.org\/10.1073\/pnas.0503726102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"34333_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.it.2006.09.004","volume":"27","author":"M Zanetti","year":"2006","unstructured":"Zanetti, M. & Franchini, G. T cell memory and protective immunity by vaccination: Is more better?. Trends Immunol. 27(11), 511\u2013517. https:\/\/doi.org\/10.1016\/j.it.2006.09.004 (2006).","journal-title":"Trends Immunol."},{"issue":"14","key":"34333_CR58","doi-asserted-by":"publisher","first-page":"8960","DOI":"10.1128\/JVI.79.14.8960-8968.2005","volume":"79","author":"EJ Wherry","year":"2005","unstructured":"Wherry, E. J., Blattman, J. N. & Ahmed, R. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J. Virol. 79(14), 8960\u20138968. https:\/\/doi.org\/10.1128\/JVI.79.14.8960-8968.2005 (2005).","journal-title":"J. Virol."},{"issue":"12","key":"34333_CR59","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.4049\/jimmunol.180.12.8250","volume":"180","author":"D Kamir","year":"2008","unstructured":"Kamir, D. et al. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J. Immunol. 180(12), 8250\u20138261. https:\/\/doi.org\/10.4049\/jimmunol.180.12.8250 (2008).","journal-title":"J. Immunol."},{"issue":"6","key":"34333_CR60","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1096\/fj.201500189R","volume":"30","author":"T Holowka","year":"2016","unstructured":"Holowka, T. et al. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence. FASEB J. 30(6), 2249\u20132265. https:\/\/doi.org\/10.1096\/fj.201500189R (2016).","journal-title":"FASEB J."},{"issue":"31","key":"34333_CR61","doi-asserted-by":"publisher","first-page":"E2117","DOI":"10.1073\/pnas.1206573109","volume":"109","author":"T Sun","year":"2012","unstructured":"Sun, T. et al. A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria. Proc. Natl. Acad. Sci. USA. 109(31), E2117\u2013E2126. https:\/\/doi.org\/10.1073\/pnas.1206573109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"1","key":"34333_CR62","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/s41467-018-05041-7","volume":"9","author":"A Baeza Garcia","year":"2018","unstructured":"Baeza Garcia, A. et al. Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection. Nat. Commun. 9(1), 2714. https:\/\/doi.org\/10.1038\/s41467-018-05041-7 (2018).","journal-title":"Nat. Commun."},{"issue":"1","key":"34333_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/tropicalmed5010046","volume":"5","author":"T Holowka","year":"2020","unstructured":"Holowka, T. & Bucala, R. Role of host and parasite MIF cytokines during Leishmania infection. Trop. Med. Infect. Dis. 5(1), 46. https:\/\/doi.org\/10.3390\/tropicalmed5010046 (2020).","journal-title":"Trop. Med. Infect. Dis."},{"issue":"5\u20136","key":"34333_CR64","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1051\/vetres:2005033","volume":"36","author":"RT Fujiwara","year":"2005","unstructured":"Fujiwara, R. T. et al. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis. Vet. Res. 36(5\u20136), 827\u2013838. https:\/\/doi.org\/10.1051\/vetres:2005033 (2005).","journal-title":"Vet. Res."},{"key":"34333_CR65","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","volume":"10","author":"A Dayakar","year":"2019","unstructured":"Dayakar, A. et al. Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: Opportunities for novel diagnostics and immunotherapy. Front. Immunol. 10, 670. https:\/\/doi.org\/10.3389\/fimmu.2019.00670 (2019).","journal-title":"Front. Immunol."},{"key":"34333_CR66","doi-asserted-by":"publisher","first-page":"10706","DOI":"10.1038\/srep10706","volume":"5","author":"S Anand","year":"2015","unstructured":"Anand, S. & Madhubala, R. Genetically engineered ascorbic acid-deficient live mutants of Leishmania donovani induce long lasting protective immunity against visceral leishmaniasis. Sci. Rep. 5, 10706 (2015).","journal-title":"Sci. Rep."},{"key":"34333_CR67","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/1471-2164-14-723","volume":"14","author":"I Rabhi","year":"2013","unstructured":"Rabhi, I. et al. Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite. BMC Genomics 14, 723. https:\/\/doi.org\/10.1186\/1471-2164-14-723 (2013).","journal-title":"BMC Genomics"},{"issue":"3","key":"34333_CR68","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1128\/IAI.01320-07","volume":"76","author":"DJ Gregory","year":"2008","unstructured":"Gregory, D. J., Sladek, R., Olivier, M. & Matlashewski, G. Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect. Immun. 76(3), 1186\u20131192. https:\/\/doi.org\/10.1128\/IAI.01320-07 (2008) (Epub 2007 Dec 17).","journal-title":"Infect. Immun."},{"issue":"6","key":"34333_CR69","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2174\/1566524043360212","volume":"4","author":"R Ravindran","year":"2004","unstructured":"Ravindran, R. & Ali, N. Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis. Curr. Mol. Med. 4(6), 697\u2013709. https:\/\/doi.org\/10.2174\/1566524043360212 (2004).","journal-title":"Curr. Mol. Med."},{"key":"34333_CR70","doi-asserted-by":"publisher","first-page":"631460","DOI":"10.1155\/2012\/631460","volume":"2012","author":"A Selvapandiyan","year":"2012","unstructured":"Selvapandiyan, A. et al. Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites. J. Trop. Med. 2012, 631460. https:\/\/doi.org\/10.1155\/2012\/631460 (2012).","journal-title":"J. Trop. Med."},{"issue":"2","key":"34333_CR71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/sj.cr.7310022","volume":"16","author":"L Leng","year":"2006","unstructured":"Leng, L. & Bucala, R. Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res. 16(2), 162\u2013168. https:\/\/doi.org\/10.1038\/sj.cr.7310022 (2006).","journal-title":"Cell Res."},{"issue":"4","key":"34333_CR72","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.0962-1075.2001.00271.x","volume":"10","author":"DC Jaworski","year":"2001","unstructured":"Jaworski, D. C., Jasinskas, A., Metz, C. N., Bucala, R. & Barbour, A. G. Identification and characterization of a homologue of the pro-inflammatory cytokine Macrophage Migration Inhibitory Factor in the tick, Amblyomma americanum. Insect Mol. Biol. 10(4), 323\u2013331. https:\/\/doi.org\/10.1046\/j.0962-1075.2001.00271.x (2001).","journal-title":"Insect Mol. Biol."},{"issue":"2","key":"34333_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.molbiopara.2006.10.020","volume":"151","author":"KB Miska","year":"2007","unstructured":"Miska, K. B. et al. Characterisation of macrophage migration inhibitory factor from Eimeria species infectious to chickens. Mol. Biochem. Parasitol. 151(2), 173\u2013183. https:\/\/doi.org\/10.1016\/j.molbiopara.2006.10.020 (2007).","journal-title":"Mol. Biochem. Parasitol."},{"issue":"3","key":"34333_CR74","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1645\/0022-3395(2003)089[0507:MEACOA]2.0.CO;2","volume":"89","author":"Z Wu","year":"2003","unstructured":"Wu, Z., Boonmars, T., Nagano, I., Nakada, T. & Takahashi, Y. Molecular expression and characterization of a homologue of host cytokine macrophage migration inhibitory factor from Trichinella spp. J. Parasitol. 89(3), 507\u2013515. https:\/\/doi.org\/10.1645\/0022-3395(2003)089[0507:MEACOA]2.0.CO;2 (2003).","journal-title":"J. Parasitol."},{"issue":"6","key":"34333_CR75","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1086\/511309","volume":"195","author":"DV Cordery","year":"2007","unstructured":"Cordery, D. V. et al. Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J. Infect. Dis. 195(6), 905\u2013912. https:\/\/doi.org\/10.1086\/511309 (2007).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"34333_CR76","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1128\/IAI.00902-06","volume":"75","author":"KD Augustijn","year":"2007","unstructured":"Augustijn, K. D. et al. Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect. Immunity 75(3), 1116\u20131128. https:\/\/doi.org\/10.1128\/IAI.00902-06 (2007).","journal-title":"Infect. Immunity"},{"issue":"12","key":"34333_CR77","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1182\/blood-2005-11-4334","volume":"107","author":"D Starlets","year":"2006","unstructured":"Starlets, D. et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107(12), 4807\u20134816. https:\/\/doi.org\/10.1182\/blood-2005-11-4334 (2006).","journal-title":"Blood"},{"issue":"9","key":"34333_CR78","doi-asserted-by":"publisher","first-page":"e1009944","DOI":"10.1371\/journal.ppat.1009944","volume":"17","author":"LS Hohman","year":"2021","unstructured":"Hohman, L. S. et al. Protective CD4+ Th1 cell-mediated immunity is reliant upon execution of effector function prior to the establishment of the pathogen niche. PLoS Pathog. 17(9), e1009944. https:\/\/doi.org\/10.1371\/journal.ppat.1009944 (2021).","journal-title":"PLoS Pathog."},{"issue":"9","key":"34333_CR79","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20142101","volume":"212","author":"ND Glennie","year":"2015","unstructured":"Glennie, N. D. et al. Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. J. Exp. Med. 212(9), 1405\u20131414. https:\/\/doi.org\/10.1084\/jem.20142101 (2015).","journal-title":"J. Exp. Med."},{"issue":"3","key":"34333_CR80","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1128\/cdli.9.3.568-572.2002","volume":"9","author":"S Singh","year":"2002","unstructured":"Singh, S., Kumari, V. & Singh, N. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin. Diagn. Lab. Immunol. 9(3), 568\u2013572. https:\/\/doi.org\/10.1128\/cdli.9.3.568-572.2002 (2002).","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"7","key":"34333_CR81","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.4049\/jimmunol.180.7.4825","volume":"180","author":"C Ronet","year":"2008","unstructured":"Ronet, C. et al. Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB\/c mice. J. Immunol. 180(7), 4825\u20134835. https:\/\/doi.org\/10.4049\/jimmunol.180.7.4825 (2008).","journal-title":"J. Immunol."},{"issue":"5","key":"34333_CR82","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/eji.200939455","volume":"40","author":"E Deak","year":"2010","unstructured":"Deak, E. et al. Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation. Eur. J. Immunol. 40(5), 1355\u20131368. https:\/\/doi.org\/10.1002\/eji.200939455 (2010).","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"34333_CR83","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/CVI.00473-10","volume":"18","author":"K Gidwani","year":"2011","unstructured":"Gidwani, K. et al. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin. Vaccine Immunol. 18(2), 346\u2013348. https:\/\/doi.org\/10.1128\/CVI.00473-10 (2011).","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"34333_CR84","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4269\/ajtmh.2002.66.334","volume":"66","author":"CH Costa","year":"2002","unstructured":"Costa, C. H. et al. Asymptomatic human carriers of Leishmania chagasi. Am. J. Trop. Med. Hyg. 66(4), 334\u2013337. https:\/\/doi.org\/10.4269\/ajtmh.2002.66.334 (2002).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4804","key":"34333_CR85","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.3107127","volume":"236","author":"CM Snapper","year":"1987","unstructured":"Snapper, C. M. & Paul, W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236(4804), 944\u2013947. https:\/\/doi.org\/10.1126\/science.3107127 (1987).","journal-title":"Science"},{"issue":"1","key":"34333_CR86","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.parint.2014.10.003","volume":"64","author":"A Thakur","year":"2015","unstructured":"Thakur, A., Kaur, H. & Kaur, S. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis. Parasitol. Int. 64(1), 70\u201378. https:\/\/doi.org\/10.1016\/j.parint.2014.10.003 (2015).","journal-title":"Parasitol. Int."},{"issue":"1131","key":"34333_CR87","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1098\/rstb.1984.0111","volume":"307","author":"JG Howard","year":"1984","unstructured":"Howard, J. G. & Liew, F. Y. Mechanisms of acquired immunity in leishmaniasis. Philos Trans R Soc Lond B Biol Sci. 307(1131), 87\u201398. https:\/\/doi.org\/10.1098\/rstb.1984.0111 (1984).","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"5","key":"34333_CR88","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.vaccine.2007.11.057","volume":"26","author":"RC Giunchetti","year":"2008","unstructured":"Giunchetti, R. C. et al. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Vaccine 26(5), 623\u2013638. https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.057 (2008).","journal-title":"Vaccine"},{"issue":"6","key":"34333_CR89","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1590\/s0074-02761996000600006","volume":"91","author":"W Mayrink","year":"1996","unstructured":"Mayrink, W. et al. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs. Mem. Inst. Oswaldo Cruz 91(6), 695\u2013697. https:\/\/doi.org\/10.1590\/s0074-02761996000600006 (1996).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"34333_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41541-019-0144-2","volume":"4","author":"E Petitdidier","year":"2019","unstructured":"Petitdidier, E. et al. Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis. NPJ Vaccines 4, 49. https:\/\/doi.org\/10.1038\/s41541-019-0144-2 (2019).","journal-title":"NPJ Vaccines"},{"issue":"9","key":"34333_CR91","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott, P. & Novais, F. O. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat. Rev. Immunol. 16(9), 581\u2013592. https:\/\/doi.org\/10.1038\/nri.2016.72 (2016).","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"34333_CR92","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","volume":"182","author":"S Lopez Kostka","year":"2009","unstructured":"Lopez Kostka, S. et al. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 182(5), 3039\u20133046. https:\/\/doi.org\/10.4049\/jimmunol.0713598 (2009).","journal-title":"J. Immunol."},{"issue":"16","key":"34333_CR93","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","volume":"88","author":"FP Heinzel","year":"1991","unstructured":"Heinzel, F. P., Sadick, M. D., Mutha, S. S. & Locksley, R. M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88(16), 7011\u20137015. https:\/\/doi.org\/10.1073\/pnas.88.16.7011 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"34333_CR94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/s0100-879x1998000100020","volume":"31","author":"A Ribeiro-de-Jesus","year":"1998","unstructured":"Ribeiro-de-Jesus, A., Almeida, R. P., Lessa, H., Bacellar, O. & Carvalho, E. M. Cytokine profile and pathology in human leishmaniasis. Braz. J. Med. Biol. Res. 31(1), 143\u2013148. https:\/\/doi.org\/10.1590\/s0100-879x1998000100020 (1998).","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"5069","key":"34333_CR95","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1126\/science.1636092","volume":"257","author":"M Barral-Netto","year":"1992","unstructured":"Barral-Netto, M. et al. Transforming growth factor-beta in leishmanial infection: A parasite escape mechanism. Science 257(5069), 545\u2013548. https:\/\/doi.org\/10.1126\/science.1636092 (1992).","journal-title":"Science"},{"issue":"8","key":"34333_CR96","doi-asserted-by":"publisher","first-page":"e1001633","DOI":"10.1371\/journal.pbio.1001633","volume":"11","author":"M Peine","year":"2013","unstructured":"Peine, M. et al. Stable T-bet(+)GATA-3(+) Th1\/Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation. PLoS Biol. 11(8), e1001633. https:\/\/doi.org\/10.1371\/journal.pbio.1001633 (2013).","journal-title":"PLoS Biol."},{"issue":"4","key":"34333_CR97","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/vaccines6040084","volume":"6","author":"SM Todryk","year":"2018","unstructured":"Todryk, S. M. T cell memory to vaccination. Vaccines 6(4), 84. https:\/\/doi.org\/10.3390\/vaccines6040084 (2018).","journal-title":"Vaccines"},{"issue":"4","key":"34333_CR98","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","volume":"33","author":"F Sallusto","year":"2010","unstructured":"Sallusto, F., Lanzavecchia, A., Araki, K. & Ahmed, R. From vaccines to memory and back. Immunity 33(4), 451\u2013463. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.008 (2010).","journal-title":"Immunity"},{"issue":"12","key":"34333_CR99","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.20020147","volume":"195","author":"EG Rhee","year":"2002","unstructured":"Rhee, E. G. et al. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection. J. Exp. Med. 195(12), 1565\u20131573. https:\/\/doi.org\/10.1084\/jem.20020147 (2002).","journal-title":"J. Exp. Med."},{"issue":"10","key":"34333_CR100","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.1201676","volume":"189","author":"NC Peters","year":"2012","unstructured":"Peters, N. C. et al. Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL\/6 mice. J. Immunol. 189(10), 4832\u20134841. https:\/\/doi.org\/10.4049\/jimmunol.1201676 (2012).","journal-title":"J. Immunol."},{"issue":"310","key":"34333_CR101","doi-asserted-by":"publisher","first-page":"310ra167","DOI":"10.1126\/scitranslmed.aac5477","volume":"7","author":"Z Mou","year":"2015","unstructured":"Mou, Z. et al. Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells. Sci. Transl. Med. 7(310), 310ra167. https:\/\/doi.org\/10.1126\/scitranslmed.aac5477 (2015).","journal-title":"Sci. Transl. Med."},{"key":"34333_CR102","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3389\/fimmu.2018.02420","volume":"9","author":"MS Duthie","year":"2018","unstructured":"Duthie, M. S. et al. Heterologous immunization with defined RNA and subunit vaccines enhances T cell responses that protect against Leishmania donovani. Front. Immunol. 9, 2420. https:\/\/doi.org\/10.3389\/fimmu.2018.02420 (2018).","journal-title":"Front. Immunol."},{"issue":"19","key":"34333_CR103","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.vaccine.2009.01.133","volume":"27","author":"I Okwor","year":"2009","unstructured":"Okwor, I., Liu, D. & Uzonna, J. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis. Vaccine 27(19), 2554\u20132562. https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.133 (2009).","journal-title":"Vaccine"},{"issue":"1","key":"34333_CR104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1863-2378.2008.01183.x","volume":"56","author":"AM Vale","year":"2009","unstructured":"Vale, A. M. et al. Identification of highly specific and cross-reactive antigens of Leishmania species by antibodies from Leishmania (Leishmania) chagasi naturally infected dogs. Zoonoses Public Health 56(1), 41\u201348. https:\/\/doi.org\/10.1111\/j.1863-2378.2008.01183.x (2009).","journal-title":"Zoonoses Public Health"},{"issue":"8","key":"34333_CR105","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","volume":"168","author":"Y Belkaid","year":"2002","unstructured":"Belkaid, Y. et al. CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168(8), 3992\u20134000. https:\/\/doi.org\/10.4049\/jimmunol.168.8.3992 (2002).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34333-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:04:11Z","timestamp":1683302651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34333"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34333-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7362"}}